These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 2832051)
1. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Hsiang YH; Liu LF Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051 [TBL] [Abstract][Full Text] [Related]
2. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Hsiang YH; Lihou MG; Liu LF Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710 [TBL] [Abstract][Full Text] [Related]
3. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Covey JM; Jaxel C; Kohn KW; Pommier Y Cancer Res; 1989 Sep; 49(18):5016-22. PubMed ID: 2548707 [TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341 [TBL] [Abstract][Full Text] [Related]
5. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Bowman KJ; Newell DR; Calvert AH; Curtin NJ Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322 [TBL] [Abstract][Full Text] [Related]
7. Camptothecin inhibits hsp 70 heat-shock transcription and induces DNA strand breaks in hsp 70 genes in Drosophila. Rowe TC; Couto E; Kroll DJ NCI Monogr; 1987; (4):49-53. PubMed ID: 2819731 [TBL] [Abstract][Full Text] [Related]
8. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells. Yang L; Rowe TC; Liu LF Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763 [TBL] [Abstract][Full Text] [Related]
9. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation. Utsugi T; Mattern MR; Mirabelli CK; Hanna N Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396 [TBL] [Abstract][Full Text] [Related]
11. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903 [TBL] [Abstract][Full Text] [Related]
12. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402 [TBL] [Abstract][Full Text] [Related]
13. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
14. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Hsiang YH; Jiang JB; Liu LF Mol Pharmacol; 1989 Sep; 36(3):371-6. PubMed ID: 2550774 [TBL] [Abstract][Full Text] [Related]
16. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Gupta RS; Gupta R; Eng B; Lock RB; Ross WE; Hertzberg RP; Caranfa MJ; Johnson RK Cancer Res; 1988 Nov; 48(22):6404-10. PubMed ID: 2846151 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Jaxel C; Kohn KW; Wani MC; Wall ME; Pommier Y Cancer Res; 1989 Mar; 49(6):1465-9. PubMed ID: 2538227 [TBL] [Abstract][Full Text] [Related]
18. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH; Castora FJ Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321 [TBL] [Abstract][Full Text] [Related]
19. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials. Poddevin B; Riou JF; Lavelle F; Pommier Y Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin. Jaxel C; Kohn KW; Pommier Y Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]